Whalesbook
Okay, toh Godrej Agrovet ne FY26 mein kamaal kar dikhaya hai, overall revenue ₹10,233 Crore ka record level par pahunch gaya. Ismein 9.1% ka jump hai. Profit after tax bhi 13.9% badh kar ₹440 Crore ho gaya hai.
Ab ye record revenue aaya kaise? Iske peeche sabse bada haath hai Oil Palm business ka. Is segment mein profit 68% tak uchhal gaya, thanks to volume mein double-digit growth aur palm kernel oil prices mein 46.7% ka zabardast increase (₹2,14,754 per metric tonne). Doosra bada booster tha Animal Nutrition business, jahan profit 19.3% badha aur volumes 12% grow hue. Indian market mein protein ki demand badhne se animal feed sector ko support mil raha hai.
Lekin, har segment mein celebration nahi hai. Crop Care business mein figures kaafi gir gaye. Segment profit 27.2% neeche ₹224 Crore par aa gaya. Iska reason hai kharab mausam, kam planting area aur kuch regulatory changes. Plus, distribution mein oversupply bhi ek issue bana. Creamline Dairy bhi pressure mein raha, EBITDA 33% gir kar ₹53 Crore ho gaya, kyunki doodh kharidne ka kharcha badh gaya aur usse revenue mein utna increase nahi ho paya.
Achhi baat ye hai ki subsidiary Astec LifeSciences ne ek achha comeback kiya hai. FY25 ke loss se nikal kar, ab revenue 17.5% badh gaya hai aur company break-even ke kareeb hai.
Company ne apni balance sheet bhi strong ki hai. Net working capital ko 25 din tak le aaye hain (pehle 39 din tha) aur return on capital employed 20% ho gaya hai. Ye operational efficiency dikhata hai.
Abhi share ka P/E ratio lagbhag 55x chal raha hai, jo UPL (around 25x) aur Coromandel International (around 35x) jaise competitors se zyada hai. Analysts ka target price ₹980 se ₹1,050 ke beech hai. Market dekhega ki management Crop Care segment mein kaise sudhar lata hai aur high-growth divisions mein momentum kaise banaye rakhta hai.